Metabolomic heterogeneity of pulmonary arterial hypertension

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Zhao, Yidan ^a   Peng, Jenny ^a   Lu, Catherine ^a   Hsin, Michael ^a   Mura, Marco ^a   Wu, Licun ^a   Chu, Lei ^a   Zamel, Ricardo ^a   Machuca, Tiago ^a   Waddell, Thomas ^a   Liu, Mingyao ^a   Keshavjee, Shaf ^a   Granton, John ^a   De Perrot, Marc ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; ADRENIC ACID; ALIPHATIC DICARBOXYLIC ACID; CARNITINE; FATTY ACID; FRUCTOSE; FRUCTOSE 6 PHOSPHATE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATASE SUBUNIT C3; HEXANOIC ACID; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; ISOCITRATE DEHYDROGENASE 1; MALONYL COENZYME A DECARBOXYLASE; MYRISTIC ACID; OCTANOIC ACID; PALMITOLEIC ACID; SORBITOL; SUCCINIC ACID; UNCLASSIFIED DRUG;

6 PHOSPHOFRUCTO 2 KINASE FRUCTOSE 2, 6 BIPHOSPHATASE 2 GENE; ACETYL COA ACETYL TRANSFERASE 1 GENE; ACETYL COA CARBOXYLASE ISOFORM A GENE; ACETYL COA SYNTHASE L1 GENE; ACYL COA DEHYDROGENASES ISOFORMS M GENE; ADULT; ALDEHYDE DEHYDROGENASE 18 FAMILY MEMBER A1 GENE; AMINO ACID METABOLISM; ARTICLE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME SYNTHESIS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; GENE; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN TISSUE; ISOCITRATE DEHYDROGENASE 1 GENE; LACTATE DEHYDROGENASE B GENE; LIPID STORAGE; MALE; MALONYL COA DECARBOXYLASE GENE; METABOLITE; METABOLOMICS; OXIDATION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SUCLA2 GENE; DISEASE COURSE; DNA MICROARRAY; LUNG; METABOLISM; OXIDATION REDUCTION REACTION; PULMONARY ARTERY; UPREGULATION;

ADULT; CITRIC ACID CYCLE; DISEASE PROGRESSION; FATTY ACIDS; FEMALE; GLYCOLYSIS; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; METABOLOMICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATION-REDUCTION; PULMONARY ARTERY; UP-REGULATION;

EID: 84895772091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088727     Document Type: Article

References (27)

1. Hassoun PM, M Mea, Barnett CF, et al. (2013) 5th World Symposium of Pulmonary Hypertension, Nice.
2. Rabinovitch M (1997) The committed vascular smooth muscle cell: a question of "timing" or "response to pressure" or both. Am J Respir Cell Mol Biol 16: 364-365.
3. Farber HW, Loscalzo J (2004) Pulmonary arterial hypertension. N Engl J Med 351: 1655-1665.
4. Izikki M, Guignabert C, Fadel E, Humbert M, Tu L, et al. (2009) Endothelialderived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J Clin Invest 119: 512-523.
5. Sanchez O, Marie E, Lerolle U, Wermert D, Israel-Biet D, et al. (2010) Pulmonary arterial hypertension in women. Rev Mal Respir 27: e79-87.
6. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M (2007) A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 30: 1103-1110. (Pubitemid 351194756)
7. Fessel JP, Hamid R, Wittmann BM, Robinson LJ, Blackwell T, et al. (2012) Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming. Pulm Circ 2: 201-213.
8. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, et al. (2005) Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65: 613-621.
9. Chen Z, Lu W, Garcia-Prieto C, Huang P (2007) The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr 39: 267-274. (Pubitemid 47619379)
10. Tuder RM, Davis LA, Graham BB (2012) Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension. Am J Respir Crit Care Med 185: 260-266.
11. Pugh ME, Robbins IM, Rice TW, West J, Newman JH, et al. (2011) Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Heart Lung Transplant 30: 904-911.
12. Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, et al. (2007) Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 115: 1275-1284. (Pubitemid 46594772)
13. Archer SL, Weir EK, Wilkins MR (2010) Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 121: 2045-2066.
14. Sutendra G, Bonnet S, Rochefort G, Haromy A, Folmes KD, et al. (2010) Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension. Sci Transl Med 2: 44ra58.
15. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
16. Lazarow PB (1978) Rat liver peroxisomes catalyze the beta oxidation of fatty acids. J Biol Chem 253: 1522-1528.
17. Kunau WH, Dommes V, Schulz H (1995) beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res 34: 267-342.
18. Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, et al. (2005) Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96: 442-450. (Pubitemid 40354538)
19. Piao L, Fang YH, Cadete VJ, Wietholt C, Urboniene D, et al. (2010) The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med (Berl) 88: 47-60.
20. Shimoda LA, Manalo DJ, Sham JS, Semenza GL, Sylvester JT (2001) Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol Lung Cell Mol Physiol 281: L202-208.
21. Michelakis ED, McMurtry MS, Wu XC, Dyck JR, Moudgil R, et al. (2002) Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation 105: 244-250. (Pubitemid 34084326)
22. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, et al. (2004) Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95: 830-840. (Pubitemid 39390586)
23. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314.
24. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008) Redox regulation of cell survival. Antioxid Redox Signal 10: 1343-1374.
25. Nordlie RC, Foster JD (2010) A retrospective review of the roles of multifunctional glucose-6-phosphatase in blood glucose homeostasis: Genesis of the tuning/retuning hypothesis. Life Sci 87: 339-349.
26. Neermann J, Wagner R (1996) Comparative analysis of glucose and glutamine metabolism in transformed mammalian cell lines, insect and primary liver cells. J Cell Physiol 166: 152-169. (Pubitemid 26017790)
27. Zhou KG, Jiang LJ, Shang Z, Wang J, Huang L, et al. (2012) Potential application of IDH1 and IDH2 mutations as prognostic indicators in nonpromyelocytic acute myeloid leukemia: a meta-analysis. Leuk Lymphoma 53: 2423-2429.